Clinical Commissioning Policies
This page lists the Clinical Commissioning Policies – known locally as Lavender Statements – that have been adopted by OCCG’s Board. NHS organisations caring for Oxfordshire patients must take account of these statements when considering treatment or referral to other specialists.
153b Excess Treatment Costs
160b Methylphenidate and Atomoxetine for ADHD
172d Carpal Tunnel Syndrome
173e Circumcision and Preputioplasty
174d Dupuytren's Contracture Release
175d Trigger Finger
177b Atomoxetine in Adults with ADHD
178c Adult ADHD Treatment Pathway Policy Statement
178c Adult ADHD Treatment Visitors Pathway
179e Anterior Cruciate Ligament Reconstruction
181c Smoking Cessation Prior to Elective Surgery
182c Athroscopic Lavage
201d Biological Disease Modifying Drugs
203b Cholecystectomy for Asymptomatic Pts
204b Surgical Removal of Anal Skin Tags